ArticleStem cell research & therapeutics2018

Cancer Subclones Derived from the Patient's Head and Neck Squamous Cell Carcinoma Tumor Stem Cells for the Screening of Personalized Antitumor Immunotherapy and Chemotherapy.

Shengwen Calvin Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.